Artículos de revistas
Conventional and alternative antifungal therapies to oral candidiasis
Registro en:
Brazilian Journal of Microbiology. Sociedade Brasileira de Microbiologia, v. 41, n. 4, p. 824-831, 2010.
1517-8382
S1517-83822010000400001
10.1590/S1517-83822010000400001
Autor
Anibal, Paula Cristina
Sardi, Janaina de Cássia Orlandi
Peixoto, Iza Teixeira Alves
Moraes, Julianna Joanna de Carvalho
Höfling, José Francisco
Institución
Resumen
Candida-associated denture stomatitis is the most common form of oral candidal infection, with Candida albicans being the principal etiological agent. Candida adheres directly or via an intermediary layer of plaque-forming bacteria to denture acrylic. Despite antifungal therapy to treat denture stomatitis, infection is reestablished soon after the treatment ceases. In addition, many predisposing factors have been identified as important in the development of oral candidiasis, including malnourishment, common endocrine disorders, such as diabetis mellitus, antibacterial drug therapy, corticosteroids, radiotherapy and other immunocompromised conditions, such as acquired immunodeficiency syndrome (AIDS). These often results in increased tolerance to the most commonly used antifungals. So this review suggests new therapies to oral candidiasis. 824 831